top of page
Investment Objective
The Evestia Mega Cap Value SMA equally weights 20 stocks of well-established companies paying consistent dividends. These companies are often associated with stability and reliability. Investing in such stocks can provide a steady income stream from dividends they distribute.
Performance
As of
3-31-25
YTD
1 Yr
2 Yr
3 Yr
Inception
Evestia Mega Cap Value
3.30%
6.88%
9.37%
-
11.33%
iShares Russell Top 200 Value
4.35%
9.72%
14.68%
-
13.17%
S&P 500
-4.27%
8.28%
18.59%
-
16.27%
Past performance is not indicative of future results. Evestia live model performance is net of 35 bps platform and strategy fees, but not advisory fees or trading costs. Returns are hypothetical and do not reflect the actual performance of any particular account. For professional investor use only.
Portfolio Statistics*
As of
3-31-25
Evestia Mega Cap Value
iShares Russell Top 200 Value
Alpha
-0.95%
0.00
Beta
0.91
1.00
Sharpe Ratio
0.43
0.54
Upside Capture Ratio
89%
100%
Downside Capture Ratio
89%
100%
Standard Deviation
14.78%
15.02%
Risk Adjusted Returns (%)*
As of
3-31-25
Evestia Mega Cap Value
iShares Russell Top 200 Value
*Since Inception
Portfolio
Top 10 Holdings
As of
3-31-25
Abbott Laboratories
5.0%
Comcast Corp
5.0%
Exxon Mobil Corp
5.0%
Johnson & Johnson
5.0%
Lockheed Martin Corp
5.0%
Merck & Co Inc
5.0%
Portfolio Characteristics
Average Market Cap (Bln)
$194.5
Dividend Yield
2.89%
P/E Forward (12m)
17.95
5 Yr Growth
12.47
Return on Equity
27.75
Number of Holdings
20
As of
3-31-25
Pepsico Inc
5.0%
Procter & Gamble Co (The)
5.0%
TJX Companies Inc (The)
5.0%
UnitedHealth Group Inc
5.0%
Sector Exposure
Utilities
0.0%
As of
3-31-25
Consumer Defensive
15.0%
Healthcare
25.0%
Communication Services
5.0%
Technology
15.0%
Consumer Cyclical
10.0%
Financial Services
5.0%
Real Estate
0.0%
Basic Materials
0.0%
Industrials
10.0%
Energy
15.0%
Learn more about Evestia's Mega Cap Strategies.
bottom of page